Paolo Rossi

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex^®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

Alena Novotná, Jan Mareš, S. Ratcliffe et al. · European Journal of Neurology · 2011 · 464 citations

Medicine, Neurology, Pharmacology +17

Default-mode network dysfunction and cognitive impairment in progressive MS

Maria A. Rocca, Paola Valsasina, Martina Absinta et al. · Neurology · 2010 · 320 citations

Medicine, Neurology, Neuroscience +17

Fatigue in Multiple Sclerosis Is Associated with Abnormal Cortical Activation to Voluntary Movement—EEG Evidence

Letizia Leocani, B. Colombo, Giuseppe Magnani et al. · NeuroImage · 2001 · 160 citations

Medicine, Neurology, Neuroscience +10

Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis

María Trojano, Fabio Pellegrini, Damiano Paolicelli et al. · Annals of Neurology · 2009 · 144 citations · Full text

Public Health, Neurology, Early Detection +15

MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatique

Bruno Colombo, Filippo Martinelli Boneschi, Paolo Rossi et al. · Journal of Neurology · 2000 · 114 citations

Life Sciences, Neurology, Neuroscience +8